The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis
- PMID: 35347102
- PMCID: PMC8976448
- DOI: 10.12659/MSM.935671
The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis
Abstract
BACKGROUND Mouse double minute 4 (MDM4) has been extensively investigated as a negative regulator of P53, its negative feedback loop, and the effect of its genetic polymorphisms on cancers. However, many studies showed varying and even conflicting results. Therefore, we employed meta-analysis to further assess the intensity of the connection between MDM4 polymorphisms and malignancies. MATERIAL AND METHODS We searched eligible articles in 5 databases (Cochrane Library, PubMed, Web of Science, Wan Fang Database, and China National Knowledge Infrastructure) up to August 2021. Odds ratios (ORs) and 95% confidence intervals (CIs) were utilized to probe the correlation of 5 MDM4 polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with carcinomas. We employed meta-regression and subgroup analysis to probe for sources of heterogeneity; Funnel plots, Begg's test, and Egger's test were used to evaluate publication bias. Sensitivity analysis was applied to assess the stability of the study. RESULTS Twenty-two studies, comprising 77 reports with 29 853 cases and 72 045 controls, were included in our meta-analysis. We found that rs4245739 polymorphism was a factor in reducing overall cancer susceptibility (dominant model, OR=0.85, 95% CI=0.76-0.95; heterozygous model, OR=0.86, 95% CI=0.78-0.96; additive model, OR=0.87, 95% CI=0.79-0.95), especially in Asian populations, and it also reduces the risk for esophageal squamous cell carcinoma (ESCC). The remaining 4 SNPs were not associated with cancers. CONCLUSIONS The rs4245739 polymorphism might reduce the risk of malignancies, especially in Asian populations, and it is a risk-reducing factor for ESCC incidence. However, rs1563828, rs11801299, rs10900598, and rs1380576 are not relevant to cancer susceptibility.
Conflict of interest statement
Figures



Similar articles
-
The associations between MDM4 gene polymorphisms and cancer risk.Oncotarget. 2016 Aug 23;7(34):55611-55623. doi: 10.18632/oncotarget.10877. Oncotarget. 2016. PMID: 27742919 Free PMC article.
-
A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibility.Oncotarget. 2016 Nov 8;7(45):73935-73944. doi: 10.18632/oncotarget.12558. Oncotarget. 2016. PMID: 27738340 Free PMC article.
-
Five MDM4 gene polymorphisms on cancer risk: An updated systematic review and meta-analysis.Int J Biol Markers. 2021 Jun;36(2):17246008211033874. doi: 10.1177/17246008211033874. Int J Biol Markers. 2021. PMID: 34347554
-
MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high-incidence region from northern China.Asia Pac J Clin Oncol. 2022 Oct;18(5):e435-e441. doi: 10.1111/ajco.13746. Epub 2022 Jan 30. Asia Pac J Clin Oncol. 2022. PMID: 35098683
-
Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review.BMC Med Genet. 2018 Oct 19;19(1):189. doi: 10.1186/s12881-018-0704-8. BMC Med Genet. 2018. PMID: 30340465 Free PMC article.
Cited by
-
Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients.Cancers (Basel). 2023 Feb 17;15(4):1281. doi: 10.3390/cancers15041281. Cancers (Basel). 2023. PMID: 36831624 Free PMC article.
-
Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer.Curr Pharm Biotechnol. 2024;25(15):1915-1938. doi: 10.2174/0113892010265004231116092802. Curr Pharm Biotechnol. 2024. PMID: 38310451 Review.
-
Contribution of TP53 and MDM4 Genetic Polymorphisms as a Risk Factor in Non-Hodgkin Lymphoma in Adult Egyptian Patients.Clin Med Insights Oncol. 2025 Jul 3;19:11795549251352047. doi: 10.1177/11795549251352047. eCollection 2025. Clin Med Insights Oncol. 2025. PMID: 40620666 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous